1.57
전일 마감가:
$1.76
열려 있는:
$1.69
하루 거래량:
2.71M
Relative Volume:
0.55
시가총액:
$5.16M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.0161
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
+9.79%
1개월 성능:
+4.67%
6개월 성능:
-92.00%
1년 성능:
-98.58%
Aptevo Therapeutics Inc Stock (APVO) Company Profile
명칭
Aptevo Therapeutics Inc
전화
206-838-0500
주소
2401 4TH AVE., SEATTLE, WA
APVO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
APVO
Aptevo Therapeutics Inc
|
1.57 | 24.30M | 12.99M | -23.72M | -23.28M | -97.25 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2018-11-05 | 개시 | Ladenburg Thalmann | Buy |
2017-10-05 | 재개 | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
Is Aptevo Therapeutics Inc. (AP81) stock inflation resilientWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
Relative strength of Aptevo Therapeutics Inc. in sector analysisChart Signals & Stock Timing and Entry Methods - newser.com
What’s the recovery path for long term holders of Aptevo Therapeutics Inc.July 2025 Update & Consistent Return Strategy Ideas - newser.com
Will Aptevo Therapeutics Inc. stock outperform international peers2025 Top Gainers & High Win Rate Trade Tips - newser.com
Does Aptevo Therapeutics Inc. show high probability of reboundTrade Exit Summary & Weekly Stock Breakout Alerts - newser.com
Why analysts raise outlook for Aptevo Therapeutics Inc. (AP81) stockJuly 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
What MACD signals say about Aptevo Therapeutics Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter - ACCESS Newswire
Interim RAINIER results: Aptevo to present Phase 1b/2 AML data at ASH, SITC, BIO-Europe and ROTH this fall - Stock Titan
APVO Stock Soars After Impressive Trial Results - StocksToTrade
APVO Stock Skyrockets: What’s Fueling the Growth? - timothysykes.com
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
How sustainable is Aptevo Therapeutics Inc. stock dividend payoutJuly 2025 Pullbacks & Entry Point Strategy Guides - newser.com
How to forecast Aptevo Therapeutics Inc. trends using time seriesJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Advanced analytics toolkit walkthrough for Aptevo Therapeutics Inc.July 2025 Snapshot & Target Return Focused Picks - newser.com
Aptevo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APVO - Benzinga
Will Aptevo Therapeutics Inc. stock recover faster than marketRate Cut & Fast Entry Momentum Alerts - newser.com
Is Aptevo Therapeutics Inc. stock attractive for ETFsMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
Real time breakdown of Aptevo Therapeutics Inc. stock performanceJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com
Aptevo Therapeutics Inc (APVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):